Status:
RECRUITING
Improved Robotic-Assisted Radical Prostatectomy for Locally Advanced Prostate Cancer: Bladder Suspension and Preliminary Outcomes
Lead Sponsor:
First Affiliated Hospital of Fujian Medical University
Conditions:
Robotic-Assisted Radical Prostatectomy
Locally Advanced Prostate Cancer
Eligibility:
MALE
Phase:
NA
Brief Summary
This study is a prospective, single-center clinical trial. It aims to establish an improved robotic-assisted radical prostatectomy for treating locally advanced prostate cancer. The technique evaluate...
Eligibility Criteria
Inclusion
- prostate biopsy and clinical confirmation of high-risk prostate cancer (PSA \> 20 ng/mL, Gleason score ≥ 8, or cT stage ≥ T2c) followed by robotic-assisted radical prostatectomy
- multiparametric MRI (mpMRI) with a 3.0 T scanner for prostate or pelvic scans performed within 30 days before the operation at our center
- Eastern Cooperative Oncology Group (ECOG) performance status score between 0 and 1
- Complete clinical and prostate biopsy pathological data.
- General health is good, with no infections, autoimmune diseases, hematologic disorders, or other malignancies.
Exclusion
- Presence of surgical contraindications.
- refusal of enhanced mpMRI imaging.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06977906
Start Date
January 1 2024
End Date
January 1 2027
Last Update
May 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
first hospital affiliated of Fujian medical university
Fuzhou, Fujian, China, 350005